Copy of Discontinuance on behalf of Appellant placed on file on 28-FEB-2014 Original filed on Court File No. A-121-13

Copy of Order dated 19-FEB-2014 rendered by The Honourable Mr. Justice Pelletier The Honourable Madam Justice Dawson The Honourable Mr. Justice Mainville placed on file. Original filed on Court File No. A-121-13

Certified French language Translation of Reasons for Judgment and Judgment rendered on 05-MAR-2013 by The Honourable Mr. Justice O'Keefe filed on 04-JUL-2013 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1199 page(s) 74 - 74 and copy placed on file.

Acknowledgment of Receipt received from all parties with respect to the Public Reasons for Judgment and Judgment of the Court rendered on March 5, 2013. placed on file on 08-MAR-2013

Reasons for Judgment and Judgment dated 05-MAR-2013 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: granted Filed on 05-MAR-2013 Final Decision Certificate of Judgment entered in J. & O. Book, volume 1186 page(s) 50 - 50

Letter from Respondent - Ranbaxy Pharmaceuticals Canada Inc. dated 04-MAR-2013 We do not believe that the Confidential Reasons for Judgment dated February 28/13 contain any confidential material. (scanned to O'Keefe, J.) received on 04-MAR-2013

Letter from Applicant dated 01-MAR-2013 We do not believe that the Confidential Reasons for Judgment dated Feb. 28/13 contain any confidential material (scanned to O'Keefe, J.) received on 01-MAR-2013

Acknowledgment of Receipt received from all parties with respect to Confidential Reasons for Judgment and Judgment issued 28-FEB-2013 placed on file on 01-MAR-2013

Reasons for Judgment and Judgment (CONFIDENTIAL VERSION) dated 28-FEB-2013 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Special Case Result: CONFIDENTIAL Filed on 28-FEB-2013 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1185 page(s) 275 - 275

Acknowledgment of Receipt received from all parties, via electronic mail, with respect to Doc. No. 28 placed on file on 31-JAN-2013

Order dated 30-JAN-2013 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Meeting Result: "...the stay period set by the Order of 30-NOV-2012 is further extended to 2-MAR-2013 pursuant to paragraph 7(5)(b) of the Regulations"; Filed on 30-JAN-2013 copies sent to parties entered in J. & O. Book, volume 1182 page(s) 266 - 267 Interlocutory Decision

Communication to the Court from the Registry dated 29-JAN-2013 re: Respondent's Letter, received 29-JAN-2013;

Letter from Respondent, Ranbaxy Pharmaceuticals Canada Inc., dated 29-JAN-2013 providing consent, on behalf of all parties, to an extension of the statutory stay which will now expire on 02-MAR-2013; received on 29-JAN-2013

Ottawa 28-JAN-2013 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Meeting Result of Hearing: statutory stay to be extended to March 2013; held by way of Conference Call Duration per day: 28-JAN-2013 from 03:32 to 03:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Anil Kamal Total Duration: 3min Appearances: Ms. Yoon Kang (416) 595-2756 representing Applicants Mr. Ron Dimock & Mr. Geoff Mowatt (647) 288-9524 representing Respondents Comments: Respondents to provide letter to the Court formally requesting stay to be extended; Minutes of Hearing entered in Vol. 874 page(s) 442 - 443 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice O'Keefe dated 28-JAN-2013 directing that a meeting will take place, via teleconference, in Ottawa at 3:30 p.m. 28-JAN-2013, with parties to remain in their respective offices; placed on file on 28-JAN-2013 Confirmed in writing to the party(ies)

Letter from Applicants dated 14-DEC-2012 requesting a brief teleconference with Justice O'Keefe on either December 18 or 19, 2012. Scanned to Justice O'Keefe's office on December 14, 2012. received on 14-DEC-2012

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Order of the Court dated 30-NOV-2012 placed on file on 04-DEC-2012

Order dated 30-NOV-2012 rendered by The Honourable Mr. Justice O'Keefe Matter considered with personal appearance The Court's decision is with regard to Letter from Applicant dated 28-NOV-2012 Result: "1. The 24 month stay in this proceeding, established by paragraph 7(1)(e) of the 'Patented Medicines (Notice of Compliance) Regulations', is extended by two months. 2. There shall be no order as to costs." Filed on 30-NOV-2012 copies sent to parties entered in J. & O. Book, volume 1176 page(s) 211 - 212 Interlocutory Decision

Ottawa 30-NOV-2012 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Meeting Result of Hearing: Order to be issued held by way of Conference Call Duration per day: 30-NOV-2012 from 09:01 to 09:04 Courtroom : Judge's Chambers - Ottawa Court Registrar: Victoria Bell Total Duration: 3 mins Appearances: Ms. Yoon Kang 416-595-2756 representing Applicant Ms. Angela Furlanetto 647-288-9530 representing Respondent, Ranbaxy Minutes of Hearing entered in Vol. 871 page(s) 481 - 482 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice O'Keefe dated 29-NOV-2012 directing that a meeting will take place via teleconference on Friday, November 30, 2012 at 9:00a.m. for a duration of 15 minutes placed on file on 29-NOV-2012 Confirmed in writing to the party(ies)

Letter from Applicant dated 28-NOV-2012 on consent of the Respondent requesting a brief teleconference with the Court on Friday, November 30, 2012 if possible. - scanned to O'Keefe, J. - received on 29-NOV-2012

Ottawa 08-NOV-2012 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Meeting Result of Hearing: parties to keep the Court updated; held by way of Conference Call Duration per day: 08-NOV-2012 from 15:00 to 15:05 Courtroom : Ottawa Registry Office Court Registrar: Anil Kamal Total Duration: 5min Appearances: Ms. Yoon Kang (416) 593-5514 representing Applicants Ms. Angela Furlanetto (647) 288-9530 representing Respondents Minutes of Hearing entered in Vol. 870 page(s) 371 - 372 Abstract of Hearing placed on file

Acknowledgment of Receipt received from both parties, via electronic mail, with respect to the Court's Direction rendered 7-NOV0-2012 placed on file on 07-NOV-2012

Oral directions received from the Court: The Honourable Mr. Justice O'Keefe dated 07-NOV-2012 directing that the Court will convene a teleconference on 8-NOV-2012 at 15:00 for a duration of a half hour with counsel to remain in their respective offices; placed on file on 07-NOV-2012 Confirmed in writing to the party(ies)

Letter from Applicants dated 06-NOV-2012 asking for a brief conference call stemming from the hearing of Sept.10-12, 2012; received on 06-NOV-2012

Transcript of hearing held at Toronto on 28-SEP-2012 received on 28-SEP-2012 Sent directly to presiding Judge 517 pages (including covering pages).

Respondent's Compendium received on 11-SEP-2012

Supplemental Book of Authorities received on 10-SEP-2012

Applicant's Compendium received on 10-SEP-2012

Copy of the 647 patent received on 10-SEP-2012

Toronto 10-SEP-2012 BEFORE The Honourable Mr. Justice O'Keefe Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Bill Evans Duration per day: 10-SEP-2012 from 09:30 to 04:30 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Andrew Murray 11-SEP-2012 from 09:30 to 04:30 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Andrew Murray 12-SEP-2012 from 09:30 to 10:35 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Andrew Murray Total Duration: 2d 1h 5min Appearances: Yoon Kang 416-593-5514 representing Applicant Vik Tenekjian 416-593-5514 representing Applicant Kyle Ferguson 416-593-5514 representing Applicant Angela M. Furlanetto 416-971-7202 representing Respondent Geoffrey D. Mowatt 416-971-7202 representing Respondent Court Reporter: Cynthia Yan 416-861-8720 10-SEP-2012 Transcript requested Comments: Applicant's and Respondent's submitted compendia. A copy of the original patent, and the applicant's submitted supplemental authorities. Minutes of Hearing entered in Vol. 867 page(s) 319 - 322 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Angela M. Furlanetto confirming service of Doc. 25 and Book of Authorities upon Applicant by personal service on 28-JUN-2012 confirming service Doc. 25 and Book of Authorities upon Respondent, The Minister of Health by personal service on 28-JUN-2012 filed on 28-JUN-2012

Book of Authorities consisting of 2 volume(s) on behalf of Respondent, Ranbaxy Laboratories Limited received on 28-JUN-2012

Application Record (2 VOLUMES) Number of copies received/prepared: 3 on behalf of Respondent, Ranbaxy Laboratories Limited filed on 28-JUN-2012

****** CANCELLED ****** Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Book of authorities upon Plaintiff by courier on 08-JUN-2012 received on 11-JUN-2012

****** CANCELLED ****** Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 11-JUN-2012 Sent directly to Presiding Judge

Covering letter from Applicants dated 11-MAY-2012 concerning Doc. Nos. 23 24 placed on file on 11-MAY-2012

Solicitor's certificate of service on behalf of Yoon Kang confirming service of Doc. No. 23 upon all respondents by personal service on 11-MAY-2012 filed on 11-MAY-2012

Application Record (4 volumes) + Appendices A&B (2 volumes) Number of copies received/prepared: 3 on behalf of Applicants filed on 11-MAY-2012

Acknowledgment of Receipt received from the parties with respect to doc. 22 served by fax placed on file on 07-MAR-2012

Order dated 07-MAR-2012 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 06-MAR-2012 re: draft order on consent for extention of time Result: 1) The Applicant's Applicantion Record shall be served and filed by 11-MAY-2012. 2) Ranbaxy's Responding Application Record shall be served and filed by 28-JUN-2012. 3) There are no costs to this order Filed on 07-MAR-2012 certified copies sent to parties entered in J. & O. Book, volume 1152 page(s) 74 - 75 Interlocutory Decision

Letter from Applicant dated 06-MAR-2012 providing the court with a draft order on consent for extension of time received on 06-MAR-2012

Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 21). placed on file on 15-DEC-2011

Order (time and place) dated 15-DEC-2011 rendered by Acting Chief Justice S Noël and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 10-SEP-2012 to begin at 09:30 duration: 3d language: E Filed on 15-DEC-2011 cc's sent to parties entered in J. & O. Book, volume 1143 page(s) 453 - 453 Transmittal letters placed on file

Affidavit of service of Michael S. Paciorek sworn on 05-DEC-2011 on behalf of Applicant confirming service of the notice of discontinuance upon Respondent by telecopier on 05-DEC-2011 filed on 05-DEC-2011

Discontinuance against Ranbaxy Pharmaceuticals Canada Inc. on behalf of Applicant filed on 05-DEC-2011

Letter from Respondent dated 28-NOV-2011 advising that on behalf of the parties no evidence is contemplated under Rule 312 of the Federal Court Rules received on 29-NOV-2011

Communication to the Court from the Registry dated 18-NOV-2011 re: Requisition for Hearing sent to JA for scheduling considering direction of September 6, 2011 setting out schedule for filing of documents.

Solicitor's certificate of service on behalf of Vik Tenekjian confirming service of Doc. No. 17 and applicant's rule 306 material upon Respondent by personal service on 16-NOV-2011 filed on 16-NOV-2011

Requisition for hearing - Application from Applicant filed on 16-NOV-2011 Tariff Application or appeal - $50.00

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 06-SEP-2011 directing that paragraphs 5 to 11 of the Direction issued on 27-APR-2011 are to be amended as follows: 5) Ranbaxy evidence on non-infringement and invalidity to be served by 16-SEP-2011; 6) Applicants' evidence on patent validity to be served by 16-NOV-2011; 7) Applicants to serve and file requisition for hearing on 16-NOV-2011; 8) Parties to advise court if any evidence is contemplated under rule 312 of the Federal Courts Rules by 28-NOV-2011 9) Cross-examinaitons to be completed by 6-MAR-2012; 10) Applicants' application record to be served and filed by 27-APR-2012; 11) Ranbaxy's responding application record to be served and filed by 14-JUN-2012. placed on file on 06-SEP-2011

Acknowledgment of Receipt received from the parties with respect to doc.16 - fax transmittal placed on file as per standing agreement placed on file on 12-SEP-2011

Order dated 12-SEP-2011 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 12-SEP-2011 Result: 1) This Application, with the consent of the parties, is dismissed, in part, insofar as it relates to Canadian Patent Nos. 1,338,377; 2,166,483; 2,166,794; 2,186,037; 2,290,531 and 2,346,988 on a without costs basis. 2) This Application, as it concerns Takeda Pharmaceutical Company Limited is dismissed, without costs. 3) Takeda Pharmaceutical Company Limited is hereby removed as a named Respondent/Patentee to this application and hte style of cause amended accordingly. 4) There are no costs to this Order Filed on 12-SEP-2011 copies sent to parties entered in J. & O. Book, volume 1134 page(s) 306 - 307 Interlocutory Decision

Communication to the Court from the Registry dated 02-SEP-2011 re: 31-AUG-2011 letter requesting amendment to scheulde set out in 27-APR-2011 direction sent to court for consideration

Letter from Respondent dated 31-AUG-2011 requesting an amendment to Prothonotary Aalto's schedule as set out in the direction of 27-APR-2011 received on 31-AUG-2011

Letter from Applicants dated 24-JUN-2011 "We enclose, for filing with the Court, an original and a copy of the Solicitor's Certificate of Service of the Applicant's evidence upon... Please note that counsel for Takeda Pharmaceuticals Canada Limited...has consented to dispense with service...Takeda has not been served with the Applicants's evidence." received on 24-JUN-2011

Solicitor's certificate of service on behalf of Vik G. Tenekjian confirming service of Applicant's Evidence on infringement upon Respondents - Ranbaxy Pharmaceuticals Canada Inc. and The Minister of Health by personal service on 24-JUN-2011 filed on 24-JUN-2011

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 27-APR-2011 directing that The timetable shall be amended as set out below: 1)_Applicants to advise the Court of any contemplated motions for further disclosure pursuant to s.6(7) of the Regulations by March 30, 2011; 2)Motion for further disclosure, if necessary, to be held by April 15, 2011; 3) Apllicants'evidence on patent infringement and factual evidence on patent validity to be served by June 24, 2011; 4)Takeda's evidence on patent infringement to be served by July 15, 2011; 5) Ranbaxy's evidence on alleged patent non-infringement and invalidity to be served by September 2, 2011; 6) Applicants' evidence on patent validity to be served by November 2, 2011; 7)Applicants to serve and file Requisition for Hearing on November 2, 2011; 8) Parties to advise Court if any evidence is contemplated under Rule 312 of the Federal Court Rules by November 14, 2011; 9) Cross-examinations to be completed by February 21, 2012; 10) Applicants' Application Record shall be served and filed by April 13, 2012; 11) Takeda's Responding Application Record shall be served and filed by May 4, 2012 and; 12) Respondent's Responding Application Records shall be served and filed by June 14, 2012 placed on file on 27-APR-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 18-MAR-2011 re: timetable placed before Prothonotary Aalto

Letter from the Applicants dated 18-MAR-2011 providing the court with a joint proposed timetable for filing received on 18-MAR-2011

Letter from Applicant dated 16-MAR-2011 requesting the courts indulgence as the parties seek to resolve outstanding issues without the assistance of the Court received on 16-MAR-2011

Acknowledgment of Receipt received from the Parties with respect to Doc. 14 by fax on 16-MAR-2011 placed on file on 16-MAR-2011

Order dated 16-MAR-2011 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: Re: Draft Order emailed to the court on 09-FEB-2011 granted Filed on 16-MAR-2011 certified copies sent to parties entered in J. & O. Book, volume 1117 page(s) 330 - 332 Interlocutory Decision

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 03-MAR-2011 directing that the 15 day extension requested in the letter dated 1-MAR-2011 has been granted placed on file on 03-MAR-2011

Letter from Applicant dated 01-MAR-2011 requesting a further 15 days to advise the Court whether a motion for disclosure is necessary... received on 01-MAR-2011

Acknowledgment of Receipt received from the parties with respect to Doc.13 fax confirmation on file placed on file on 07-FEB-2011

Order dated 07-FEB-2011 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from the parties dated 26-JAN-2011 Result: Protective Order on consent Filed on 07-FEB-2011 copies sent to parties entered in J. & O. Book, volume 1114 page(s) 390 - 401 Interlocutory Decision

Communication to the Court from the Registry dated 04-FEB-2011 re: re: Applicant's letter dated 04-FEB-2011

Letter from Applicant dated 04-FEB-2011 providing the court with draft verification Order on consent received on 04-FEB-2011

Communication to the Court from the Registry dated 31-JAN-2011 re: Sent to Court for review

Letter from Applicant dated 26-JAN-2011 We respectfully submit a draft Protective Order, filed with the executed consent of the parties, for the Court's review and consideration received on 26-JAN-2011

Letter from the Applicants dated 24-JAN-2011 requesting a few extra days to come to terms with the draft Protective Order received on 24-JAN-2011

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 23-DEC-2010 directing that Counsel for the Applicants have written to the Court by letter dated December 20, 2010 on behalf of the parties with an agreed upon schedule for the steps in this proceeding. The proposed schedule is approved. The parties should confer and advise the Court of the number of days it is anticipated that the hearing will take. In the event that any motions are to be brought, the parties shall request a case conference with the Court prior to filing any motion in order to review the scope and necessity of such motion and, if required to set a schedule for the hearing of such motion. THe parties may contact the COurt at any time to arrange a case conference in the event any issues arise concerning the conduct of this proceeding. Any amendments to the schedule may be sought on consent by way of letter to the Court and in not on consent then by way of case conference. placed on file on 23-DEC-2010

Order dated 21-DEC-2010 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Status Review Result: IT IS ORDERED pursuant to Rule 383 that prothonotary Kevin Aalto is assigned as Case Management Judge in this matter. Filed on 22-DEC-2010 certified copies sent to parties entered in J. & O. Book, volume 1109 page(s) 391 - 391 Interlocutory Decision

Letter from Applicant dated 20-DEC-2010 providing the court with proposed joint schedule received on 21-DEC-2010

Affidavit of service of Stewart Martin sworn on 03-DEC-2010 on behalf of Applicant confirming service of Doc 1 upon Ranbaxy Pharmaceuticals Canada Inc., Respondent by personal service on 02-DEC-2010 filed on 09-DEC-2010

Affidavit of service of Pamela Tuchlin sworn on 07-DEC-2010 on behalf of Applicant confirming service of Doc 1 upon The Deputy Attorney General of Canada by personal service on 02-DEC-2010 filed on 09-DEC-2010

Affidavit of service of P. Claire Gordon sworn on 03-DEC-2010 on behalf of Applicant confirming service of Doc 1 upon The Minister of Health, Respondent by personal service on 02-DEC-2010 filed on 09-DEC-2010

Affidavit of service of P. Claire Gordon sworn on 03-DEC-2010 on behalf of Applicant confirming service of Doc 1 upon Takeda Pharmaceutical Company Limited, Respondent/Patentee by personal service on 02-DEC-2010 filed on 09-DEC-2010

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 09-DEC-2010 directing that The parties shall, within ten days of the date of this direction, file a joint proposal for a timetable to govern the steps in this proceeding, and incorporating into the timetable, any motions that could be contemplated, including any motions relating to protective or confidentiality orders, production pursuant to ss.6(7) of the PMNOC Regulations, verification orders , leave to file additional affidavits pursuant to Rule 312 of the Federal Courts Rules or motions pursuant to ss.6(5) of the PMNOC Regulations. The timetable shall address the order of evidence to be served and filed and shall also incorporate dates by which parties shall confirm by letter, whether or not any of the contemplated motions will be brought and which letter shall include dates for a case management teleconference to be conducted prior to any motion being filed. In the event the parties cannot agree to a timetable each shall, within the ten days, file an independent proposal and dates of mutual availability for a case management teleconference placed on file on 09-DEC-2010 Confirmed in writing to the party(ies)

Solicitor's certificate of service on behalf of Angela M. Furlanetto confirming service of Doc 6 upon all parties by telecopier on 03-DEC-2010 filed on 06-DEC-2010

Notice of appearance on behalf of Respondent, Ranbaxy Pharmaceuticals Canada Inc. filed on 06-DEC-2010

Service copy of Doc. No. 1 with proof of service upon MOH on 03-DEC-2010 filed on 03-DEC-2010

Notice of appearance on behalf of Respondent(Minister of Health) with proof of service upon Applicant on 03-DEC-2010 Respondents(Ranbaxy and Takeda) on 03-DEC-2010 filed on 03-DEC-2010

Affidavit of service of Danial Esseltine sworn on 03-DEC-2010 on behalf of Respondent/Patentee Takeda Pharmaceutical Company Limited confirming service of Notice of Appearance doc.no.2 upon all parties by telecopier on 03-DEC-2010 filed on 03-DEC-2010

Notice of appearance on behalf of Respondent/Patentee Takeda Pharmaceutical Company Limited filed on 03-DEC-2010

Notice of application and 2 copies with regard to Judicial Review (s.18) filed on 02-DEC-2010 Tariff fee of $50.00 received: yes